Lilly sponsored the clinical trial, the goal of which, the company said, was to demonstrate Zepbounds superiority in percent change from baseline in body weight at 72 weeks compared to Wegovy. This shouldnt necessarily raise eyebrows, says Dr
Theres different ways to try to get this into the diets because its not always easy to get them to eat their whole-food, high-fibre diets, he says
[1] In the SURMOUNT-1 clinical trial, higher doses in non-diabetic adults demonstrated significant weight loss, with participants losing approximately 15-20% of body weight over 72 weeks
However, individual circumstances vary, and factors such as gastrointestinal side effects, medication absorption, and overall seizure control require careful consideration
When will pharmacies actually have it
Yes, combining metformin with tirzepatide is safe for most type 2 diabetes patients and is supported by clinical evidence